15 October 2024
Dr. Harvey Kok Pediatric Respiratory and Sleep Medicine Physician
Dr. Caitlin Kenna Paediatric Advance Trainee
Dr. Katherine Coppinger Paediatric Basic Trainee
Chronic lung allograft dysfunction: Bronchiolitis obliterans syndrome
Flanagan, Frances et al. Post-infectious bronchiolitis obliterans in children. Paediatric respiratory reviews vol. 42 (2022): 69-78. doi:10.1016/j.prrv.2022.01.007
Kavaliunaite, Ema, and Paul Aurora. Diagnosing and managing bronchiolitis obliterans in children. Expert review of respiratory medicine vol. 13,5 (2019): 481-488. doi:10.1080/17476348.2019.1586537
BMJ Best Practice Bronchiolitis obliterans organising pneumonia
Ringholz, Fiona et al. Managing end stage lung disease in children. Paediatric respiratory reviews vol. 15,1 (2014): 75-80; quiz 80-1. doi:10.1016/j.prrv.2013.07.002
Paraskeva, Miranda A et al. Lung transplantation in Australia, 1986-2018: more than 30 years in the making. The Medical journal of Australia vol. 208,10 (2018): 445-450. doi:10.5694/mja17.00909
Leard, Lorriana E et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 40,11 (2021): 1349-1379. doi:10.1016/j.healun.2021.07.005
Gokturk B.Successful Therapy with intravenous gamma globulin in two children with postinfectious bronchiolitis obliterans. Journal of Pulmonology and Respiratory Research. 2017;1:009-12.
Khandelwal, Pooja et al.Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 23,7 (2017): 1122-1127. doi:10.1016/j.bbmt.2017.03.029
Schoettler, Michelle et al.Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation. Bone marrow transplantation vol. 54,7 (2019): 1158-1160. doi:10.1038/s41409-019-0450-3
Schoettler, Michelle et al.Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation. Bone marrow transplantation vol. 54,7 (2019): 1158-1160. doi:10.1038/s41409-019-0450-3
Back